Evidence map›Paper›PMID 38129309›Full record

ReviewZhonghua shao shang yu chuang mian xiu fu za zhi2023

[Research progress of mucormycosis in burns].

T Shen, F Zhu

Open access · greenAbstract readReviewEnglish Abstract
In one paragraph

Review in Zhonghua shao shang yu chuang mian xiu fu za zhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

T ShenDepartment of Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Shanghai 200120, China.
F ZhuBurn Department, the First Affiliated Hospital, Naval Medical University, Shanghai 200433, China.
Shanghai Changzheng Hospital · CNShanghai East Hospital · CN

Funding

National Key Research and Development Program "Stem Cell and Transformation Research" Key Special Project 2019YFA0110602
6 · The paper itself

Abstract

Mucormycosis is a relatively rare but dangerous infectious diseases. Burn patients, especially severe burn patients, are at high risk of mucormycosis. In recent years, the incidence of mucormycosis in burn patients has increased. At present, there are a few domestic literatures on mucormycosis in burns, with most being case reports without systematic summary. Based on the relevant literature at home and abroad in recent years, this article reviewed the epidemiological characteristics, clinical manifestations, diagnostic methods, and treatment methods of mucormycosis in burns, hoping to provide some basis for the diagnosis and treatment of mucormycosis in burns in China.

Indexed as

BurnsMucormycosisAntifungal AgentsChinaDebridementHumansAntifungal Agents

Identifiers

PMID38129309
PMCPMC11630400
OpenAlexW4390120736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.